Labcorp to introduce combined oncology offering at 2021 ASCO® annual meeting

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 2, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American Society of Clinical Oncology (ASCO®) Annual Meeting held June 4-8 .

OmniSeq receives New York state approval for OmniSeq INSIGHT genomic and immune profiling test

BUFFALO, N.Y., April 28, 2021 - OmniSeq®, an innovator in next generation sequencing in oncology, today announced the New York State Department of Health's Clinical Laboratory Evaluation Program has approved the OmniSeq INSIGHTSM  test. The test detects genomic variants, genomic signatures, and immune gene expression, providing physicians with clinically actionable evidence to inform therapeutic treatment decisions and identify potential clinical trial options for patients with late-stage solid tumor cancers.